Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Adaptation of the Geant4 ICRP110 Human Phantom advanced example for nuclear medicine applications to allow overlay of lesions as Geant4 parallel world objects

Muhammad Salman, Matthew Large, Anatoly Rosenfeld, Susanna Guatelli and Alessandra Malaroda
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1586;
Muhammad Salman
1University of Wollongong Wollongong Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Large
1University of Wollongong Wollongong Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anatoly Rosenfeld
1University of Wollongong Wollongong Australia
2IHMRI, University of Wollongong Wollongong Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanna Guatelli
2IHMRI, University of Wollongong Wollongong Australia
1University of Wollongong Wollongong Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Malaroda
3Theranostics and Nuclear Medicine Department, St Vincent’s Public Hospital Sydney Australia
1University of Wollongong Wollongong Australia
2IHMRI, University of Wollongong Wollongong Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1586

Introduction: The Geant4 application ‘ICRP110_HumanPhantom’ [1] has recently been implemented as an advanced example in version 10.7 of the Geant4 Monte Carlo Toolkit (https://geant4.web.cern.ch/node/1910). This advanced example implements the adult male and adult female voxelised phantoms published in the ICRP 110 [2] and allows the estimation of radiation doses to single voxels and phantom organs from any radiation field incident on the phantom. In this study, the ICRP110_HumanPhantom was adapted to estimate voxel and organ doses from the internalisation of radionuclides in organs and in lesions that can be positioned within the phantom. The lesions are objects of any shape and/or material composition whose position in the Geant4 simulation can be controlled by the user.

Methods: This implementation of the ICRP110_HumanPhantom, developed in Geant4 version 10.4p01, makes use of the EM Livermore Physics List for modelling particle interactions and of the G4ParticleGun Class to randomly select particles’ initial position, momentum and direction of travel within selected organ(s) or within user defined lesion(s). Lesions are implemented using the Geant4 Parallel World functionality and they can be positioned to overlap the voxelised phantom. The Geant4 code was benchmarked by comparing organ doses from mono-energetic photons and electrons uniformly distributed within organs against OpenDose data [3]. As an example of the code functionality, spherical lesions of 0.5, 1 and 2 cm radius were positioned, in a Geant4 Parallel World, central to the ICRP110 adult male liver, keeping the same material composition as the ICRP110 liver [2]. The isotope 90Y was uniformly distributed in the tumours and 50 runs of 106 particles were simulated to evaluate absorbed doses per disintegration to the lesion and to all the ICRP110 organs. Self-dose to the spherical lesions was compared to the values published by Bardies and Chatal [4].

Results: Good agreement between absorbed doses to organs from uniform distribution of mono-energetic electrons and photons in source organs were observed when compared to OpenDose data [3]. Absorbed doses per disintegration to the lesion, liver, spleen, right and left kidneys from spherical lesions are shown in Table 1. Good agreement between self-dose and Bardies and Chatal [4] data was achieved. Conclusion: The Geant4 ICRP110_HumanPhantom advanced example has been adapted to 1. allow users to generate sources within the phantom organs and user defined lesion(s) and 2. record absorbed doses in all the ICRP 110 organs and in the lesion(s). In fact, the use of the Geant4 Parallel World adds the flexibility to input one or more non-spherical lesions within the ICRP110 phantom and to estimate absorbed doses to organs from these lesions. Currently, the code is being imported to the newest version of Geant4 (10.7), this should not have any impact on the validity of the results presented. It is envisaged that this adaptation of the Geant4 ICRP110_HumanPhantom application, of interest for internal dosimetric estimations, will be implemented in future versions of the Geant4 advanced example.

View this table:
  • View inline
  • View popup

Table 1: Absorbed doses to lesion, spleen, liver and kidneys from spherical tumours

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adaptation of the Geant4 ICRP110 Human Phantom advanced example for nuclear medicine applications to allow overlay of lesions as Geant4 parallel world objects
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Adaptation of the Geant4 ICRP110 Human Phantom advanced example for nuclear medicine applications to allow overlay of lesions as Geant4 parallel world objects
Muhammad Salman, Matthew Large, Anatoly Rosenfeld, Susanna Guatelli, Alessandra Malaroda
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1586;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Adaptation of the Geant4 ICRP110 Human Phantom advanced example for nuclear medicine applications to allow overlay of lesions as Geant4 parallel world objects
Muhammad Salman, Matthew Large, Anatoly Rosenfeld, Susanna Guatelli, Alessandra Malaroda
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1586;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • Emerging role of FDG-PET/CT for global assessment of bone marrow involvement in chronic lymphocytic leukemia
  • Diagnostic Efficacy of Quantitative Indexes on [99mTc]DPD SPECT/CT for Cardiac Amyloidosis: Inter-Observer Agreement and Association with Conventional Scoring
Show more Poster - PhysicianPharm

Dosimetry

  • Comparison of S-Values and Absorbed Dose Rates at the Cellular Level in Prostate Cancer Cells Irradiated with 177Lu and 225Ac Labelled Compounds
  • Dosimetric analyses of intra-arterial versus standard intravenous administration of lutetium-177-DOTA octreotate in patients with Neuroendocrine tumour liver dominant metastatic disease
  • Personalized dosimetry for brain cancer radioembolization: A feasibility study
Show more Dosimetry

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire